BOX INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BOX INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jan 31, 2018 | $506.14M | Mar 22, 2018 |
| FY2018 | Jan 31, 2017 | $398.61M | Mar 22, 2018 |
| FY2018 | Jan 31, 2016 | $302.70M | Mar 22, 2018 |
| FY2017 | Jan 31, 2015 | $216.44M | Mar 24, 2017 |
| FY2016 | Jan 31, 2014 | $124.19M | Mar 30, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.18B | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $1.09B | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | $1.04B | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | $990.87M | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | $874.33M | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | $770.77M | Mar 13, 2023 |
| FY2022 | Jan 31, 2020 | $696.26M | Mar 16, 2022 |
| FY2021 | Jan 31, 2019 | $608.39M | Mar 19, 2021 |
| FY2020 | Jan 31, 2018 | $506.14M | Mar 19, 2020 |
| FY2019 | Jan 31, 2017 | $398.61M | Mar 20, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $932.61M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $862.03M | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | $777.13M | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | $738.32M | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | $624.85M | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | $546.03M | Mar 13, 2023 |
| FY2022 | Jan 31, 2020 | $480.69M | Mar 16, 2022 |
| FY2021 | Jan 31, 2019 | $434.79M | Mar 19, 2021 |
| FY2020 | Jan 31, 2018 | $370.89M | Mar 19, 2020 |
| FY2019 | Jan 31, 2017 | $286.48M | Mar 20, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $115.38M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $244.62M | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | $129.03M | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | $26.78M | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | ($41.46M) | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | ($43.43M) | Mar 13, 2023 |
| FY2022 | Jan 31, 2020 | ($144.35M) | Mar 16, 2022 |
| FY2021 | Jan 31, 2019 | ($134.61M) | Mar 19, 2021 |
| FY2020 | Jan 31, 2018 | ($154.96M) | Mar 19, 2020 |
| FY2019 | Jan 31, 2017 | ($151.79M) | Mar 20, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $83.19M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $79.63M | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | $50.75M | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | $36.84M | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | ($27.63M) | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | ($37.64M) | Mar 13, 2023 |
| FY2022 | Jan 31, 2020 | ($139.47M) | Mar 16, 2022 |
| FY2021 | Jan 31, 2019 | ($134.24M) | Mar 19, 2021 |
| FY2020 | Jan 31, 2018 | ($154.02M) | Mar 19, 2020 |
| FY2019 | Jan 31, 2017 | ($150.66M) | Mar 20, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $294.54M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $264.85M | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | $248.77M | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | $243.53M | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | $218.52M | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | $201.26M | Mar 13, 2023 |
| FY2022 | Jan 31, 2020 | $199.75M | Mar 16, 2022 |
| FY2021 | Jan 31, 2019 | $163.75M | Mar 19, 2021 |
| FY2020 | Jan 31, 2018 | $136.79M | Mar 19, 2020 |
| FY2019 | Jan 31, 2017 | $115.93M | Mar 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $356.45M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $332.26M | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | $318.73M | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | $297.98M | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | $234.82M | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | $196.83M | Mar 13, 2023 |
| FY2022 | Jan 31, 2020 | $44.71M | Mar 16, 2022 |
| FY2021 | Jan 31, 2019 | $55.32M | Mar 19, 2021 |
| FY2020 | Jan 31, 2018 | $35.39M | Mar 19, 2020 |
| FY2019 | Jan 31, 2017 | ($2.39M) | Mar 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $6.07M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $2.57M | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | $4.70M | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | $5.03M | Mar 10, 2025 |
| FY2020 | Jan 31, 2020 | $5.45M | Mar 19, 2020 |
| FY2020 | Jan 31, 2019 | $14.81M | Mar 19, 2020 |
| FY2020 | Jan 31, 2018 | $11.82M | Mar 19, 2020 |
| FY2019 | Jan 31, 2017 | $14.96M | Mar 20, 2019 |
| FY2018 | Jan 31, 2016 | $72.94M | Mar 22, 2018 |
| FY2017 | Jan 31, 2015 | $38.68M | Mar 24, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.55B | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $1.67B | Mar 9, 2026 |
| FY2025 | Jan 31, 2024 | $1.24B | Mar 10, 2025 |
| FY2024 | Jan 31, 2023 | $1.21B | Mar 11, 2024 |
| FY2023 | Jan 31, 2022 | $1.39B | Mar 13, 2023 |
| FY2022 | Jan 31, 2021 | $1.35B | Mar 16, 2022 |
| FY2021 | Jan 31, 2020 | $959.99M | Mar 19, 2021 |
| FY2020 | Jan 31, 2019 | $650.16M | Mar 19, 2020 |
| FY2019 | Jan 31, 2018 | $553.57M | Mar 20, 2019 |
| FY2018 | Jan 31, 2017 | $493.67M | Mar 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.35B | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $1.47B | Mar 9, 2026 |
| FY2025 | Jan 31, 2024 | $1.18B | Mar 10, 2025 |
| FY2024 | Jan 31, 2023 | $1.24B | Mar 11, 2024 |
| FY2023 | Jan 31, 2022 | $1.30B | Mar 13, 2023 |
| FY2022 | Jan 31, 2021 | $1.20B | Mar 16, 2022 |
| FY2021 | Jan 31, 2020 | $937.63M | Mar 19, 2021 |
| FY2020 | Jan 31, 2019 | $618.76M | Mar 19, 2020 |
| FY2019 | Jan 31, 2018 | $538.60M | Mar 20, 2019 |
| FY2018 | Jan 31, 2017 | $418.94M | Mar 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | ($299.28M) | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | ($296.96M) | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | ($431.06M) | Mar 9, 2026 |
| FY2026 | Jan 31, 2023 | ($523.85M) | Mar 9, 2026 |
| FY2025 | Jan 31, 2022 | ($395.09M) | Mar 10, 2025 |
| FY2024 | Jan 31, 2021 | $151.07M | Mar 11, 2024 |
| FY2023 | Jan 31, 2020 | $22.36M | Mar 13, 2023 |
| FY2022 | Jan 31, 2019 | $31.41M | Mar 16, 2022 |
| FY2021 | Jan 31, 2018 | $14.97M | Mar 19, 2021 |
| FY2020 | Jan 31, 2017 | $74.73M | Mar 19, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $82.29M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $76.97M | Mar 9, 2026 |
| FY2025 | Jan 31, 2024 | $76.75M | Mar 10, 2025 |
| FY2024 | Jan 31, 2023 | $73.86M | Mar 11, 2024 |
| FY2023 | Jan 31, 2022 | $74.47M | Mar 13, 2023 |
| FY2022 | Jan 31, 2021 | $18.74M | Mar 16, 2022 |
| FY2021 | Jan 31, 2020 | $18.74M | Mar 19, 2021 |
| FY2020 | Jan 31, 2019 | $18.74M | Mar 19, 2020 |
| FY2019 | Jan 31, 2018 | $16.29M | Mar 20, 2019 |
| FY2018 | Jan 31, 2017 | $16.29M | Mar 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | ($846.76M) | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | ($962.14M) | Mar 9, 2026 |
| FY2025 | Jan 31, 2024 | ($1.21B) | Mar 10, 2025 |
| FY2024 | Jan 31, 2023 | ($1.34B) | Mar 11, 2024 |
| FY2023 | Jan 31, 2022 | ($1.36B) | Mar 13, 2023 |
| FY2022 | Jan 31, 2021 | ($1.32B) | Mar 16, 2022 |
| FY2021 | Jan 31, 2020 | ($1.28B) | Mar 19, 2021 |
| FY2020 | Jan 31, 2019 | ($1.13B) | Mar 19, 2020 |
| FY2019 | Jan 31, 2018 | ($1.04B) | Mar 20, 2019 |
| FY2018 | Jan 31, 2017 | ($884.13M) | Mar 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $375.13M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | $624.58M | Mar 9, 2026 |
| FY2025 | Jan 31, 2024 | $383.74M | Mar 10, 2025 |
| FY2024 | Jan 31, 2023 | $428.47M | Mar 11, 2024 |
| FY2023 | Jan 31, 2022 | $416.27M | Mar 13, 2023 |
| FY2022 | Jan 31, 2021 | $595.08M | Mar 16, 2022 |
| FY2021 | Jan 31, 2020 | $195.59M | Mar 19, 2021 |
| FY2021 | Jan 31, 2019 | $217.52M | Mar 19, 2021 |
| FY2021 | Jan 31, 2018 | $208.08M | Mar 19, 2021 |
| FY2020 | Jan 31, 2017 | $177.39M | Mar 19, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 0 | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | 1 | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | 0 | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | 0 | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | 0 | Mar 13, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 0 | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | 1 | Mar 9, 2026 |
| FY2026 | Jan 31, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Jan 31, 2023 | 0 | Mar 10, 2025 |
| FY2024 | Jan 31, 2022 | 0 | Mar 11, 2024 |
| FY2023 | Jan 31, 2021 | 0 | Mar 13, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 140.91M | Mar 9, 2026 |
| FY2026 | Jan 31, 2025 | 144.11M | Mar 9, 2026 |
| FY2025 | Jan 31, 2024 | 144.35M | Mar 10, 2025 |
| FY2024 | Jan 31, 2023 | 144.30M | Mar 11, 2024 |
| FY2023 | Jan 31, 2022 | 145.08M | Mar 13, 2023 |
| FY2022 | Jan 31, 2021 | 159.85M | Mar 16, 2022 |
| FY2021 | Jan 31, 2020 | 150.61M | Mar 19, 2021 |
| FY2020 | Jan 31, 2019 | 144.31M | Mar 19, 2020 |